Dedicated to research
of real-life healthcare

PHARMO Institute

PHARMO Institute is dedicated to the study of epidemiology, drug utilization, drug safety and health outcomes. As part of Lumanity, a global pharmaceutical strategic services organization, PHARMO Institute studies the effects of drug treatments in real life to enhance the health of people using medication. In that way, we contribute to drug safety and are able to find unwanted side effects in advance.

We collaborate with data partners around the world to deliver multi-country database studies. Our longstanding track-record of jointly delivering safety and outcomes research studies with these collaborators has created an optimized practice of shared working, common language, common project delivery, and a high standard of quality control – ensuring a frictionless scientific process for driving study outputs.

In addition to our data collaborations across North America and Europe, we also maintain direct access to local databases in the Netherlands derived from general practitioners, hospitals, labs, various disease related databases, and in- and out-patient pharmacies.

This data derived, from various primary and secondary healthcare settings, enables unique and innovative research use cases that can address gaps commonly found in other secondary databases. Disease areas that are addressable in the PHARMO Data Network with ease include slow-progressing illnesses, conditions managed across multiple settings, and rare diseases where ICD-10 codes are often underutilized. We offer novel solutions for the study of long-term outcomes, detection of non-severe events, inpatient treatment patterns, parent-child links, precision medicine, and disease classification algorithms.

We use data of

150 million person years
0
Patients
0
Practices in primary and secondary care
0

Who we are

Founded in 1999, PHARMO Institute is a research organization dedicated to the study of epidemiology, drug safety, and outcomes research. PHARMO Institute is part of Lumanity, a global pharmaceutical strategic services organization and together, we continue to advance our shared mission of optimizing patient access to therapies with a focus on demonstrating real world safety, effectiveness, and value.

PHARMO Institute works closely with (inter)national medical universities and global databases. Through its studies with longitudinal and real world patient data, the PHARMO Institute contributes to risk management and outcomes research and provides solutions for health authorities in safety, market access, health economics, and outcomes domains.

News updates

Read our latest updates and publications in our news section below.

Members of